References
- Wellens HJ, Bär FW, Lie KI. The value of the electrocardiogram In the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 1978: 64(1): 27–33
- Braunwald E. Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders. 1980: 724
- Weaver WD, Cobb LA. Copass MK, et al. Ventricular defibrillation: comparative trial using 175-J and 320-J shocks. N Engl J Med 1982: 307(18): 1101–6
- Harrison DC, Meffin PJ, Winkle RA. Clinical pharmacokinetics of antiarrhythmic drugs. Prog Cardlovasc Dis 1977: 20(3): 217–42
- Zipes DP, Troop PJ. New antiarrhythmic agents: amiodarone, aprindine. disopyramide. ethmozin. mexiletine. Tocainide, verapamil. Am J Cardiol 1978: 41(6): 1005–24
- Federman J, Vlietstra RE. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy. Mayo Clin Proc 1979: 54(8): 531–42
- Greenspan AM. Horowitz LN, Spielman SR. et al. Large dose procainamide therapy for ventricular tachyarrhythmia. Am J Cardiol 1980: 46(3): 453–62
- McAllister RG Jr. Clinical pharmacology of slow channel blocking agents. Prog Cardiovasc Dis 1982: 25(2): 83–102
- Talano JV, Tommaso C. Slow channel calcium antagonists In the treatment of supraventricular tachycardia. Prog Cardiovasc Dis 1982: 25(2): 141–56
- Smith WM, Gallagher JJ. ‘Les torsades de pointes’: an unusual ventricular arrhythmia Ann Intern Med 1980: 93(4): 578–84